Iron overload damages mitochondria and induces metabolic rewiring of hematopoietic stem cells toward glycolysis
Abstract
Abstract Iron is an essential element for most cellular processes, and recent evidence highlighted its role in regulating the function of hematopoietic stem cells (HSCs). Abnormal iron levels affect HSC quiescence and self-renewal; however, the mechanism by which iron overload (IO) influences HSC function is still unknown. Here, we show that intracellular IO impairs mitochondrial fitness and bioenergetics, inducing metabolic rewiring. In thalassemic mice, as a model of chronic IO, HSCs accumulate elevated mitochondrial reactive oxygen species (mtROS), low mitochondrial membrane potential, and reduced oxidative phosphorylation. Mitochondrial defects are confirmed in 2 other models of IO, sickle cell disease and iron-loaded wild-type mice, and in vivo iron reduction rescues HSC mitochondria. IO HSCs are highly proliferating and, in the presence of damaged mitochondria, rely on glycolysis for energy production. Notably, restoration of mitochondrial function by targeting in vivo mtROS improved the quiescence and self-renewal of IO HSCs. Our results unravel the critical interplay between iron, ROS, and mitochondrial activity in HSCs, revealing that IO shapes HSC metabolic programs.
Article Details
Authors (13)
Silvia Sighinolfi
1San Raffaele Telethon Institute for Gene Therapy, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy
Laura Cassina
2Division of Genetics and Cell Biology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy
Maria Rosa Lidonnici
Stefano Beretta
Davide Stefanoni
2Division of Genetics and Cell Biology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy
Mariangela Storto
Christina Mayerhofer
3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA
Trine A. Kristiansen
3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA
David T. Scadden
3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, MA
Ivan Merelli
Alessandra Boletta
2Division of Genetics and Cell Biology, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy
Annamaria Aprile
Giuliana Ferrari